MS Living Well Podcast: Personalized Medicine for MS

With over 20 options, what is the best multiple sclerosis treatment for me? Selecting an appropriate disease-modifying therapy (DMT) needs to consider your risk of worsening disability over time. Your age, sex and race can affect your prognosis and can influence the power of treatment chosen. Details about your early relapses and MRI activity are very important for treatment decisions.

Treatment selection should also consider responsiveness to vaccines, family planning and other medical problems (another autoimmune disease or cancer). For each individual living with multiple sclerosis, balancing power of treatment against serious risks of treatment needs to be considered.  The future of personalizing care to better pick the right medication shared.

Season 4 MS Living Well podcast is sponsored by Octave.

Barry Singer MD, Director of The MS Center for Innovations in Care, interviews:

Celia Oreja-Guevara MD PhD

Celia Oreja-Guevara MD PhD is the Vice Chair of Neurology and Head of the Multiple Sclerosis Center at the University Hospital, San Carlos, Madrid, Spain and an Associate Professor of Neurology at the Complutense University of Madrid, Spain. Dr Oreja-Guevara received her MD from the Complutense University of Madrid and PhD in neuroimmunology at the Max Planck Institute of Neurobiology, Munich, Germany. She completed her residency at the Ruhr-University Bochum, Germany and went on to complete a postdoctoral fellowship in neuroimaging at the San Raffaele Hospital, Milan, Italy.

John Foley MD

John Foley MD is Director of the Rocky Mountain MS Clinic in Salt Lake City, Utah which he founded in 2006. Dr. Foley earned his medical degree from the Medical College of Wisconsin and went on to complete his residency in Neurology at the University of Utah. He formerly served as Chief over the Division of Neurology at LDS Hospital in Salt Lake City.